Compounded GLP-1 has no standardized dose schedule — which makes tracking even more critical than for brand-name users. tr8ck supports any custom dose and frequency, connecting your medication data with sleep, nutrition, mood, energy, and weight to give you the full picture of how your compound formulation is working.
Brand-name Ozempic users follow a fixed dose schedule with known milestones. Compound users are navigating more personalized territory — which requires better data.
Compound semaglutide is prescribed at customized doses — often starting lower than brand-name and escalating based on individual response. Without tracking, dose decisions are made on recall and guesswork rather than actual weight, energy, and side effect data.
Compounded preparations vary between pharmacies in concentration, additives, and administration instructions. Some include B12 or other compounds. Tracking side effects carefully helps identify whether reactions are from the semaglutide itself or from adjuncts in the formulation.
Brand-name Ozempic has documented population-level outcomes at each dose. Compound users don't have that reference point — their personal tracking data IS their benchmark. tr8ck builds this from day one.
Telehealth prescribers managing compound GLP-1 patients have less face time than traditional clinic relationships. Bringing objective tracked data — weight trends, side effect severity scores, energy patterns — to consultations leads to better dose decisions and outcomes.
tr8ck's medication module is built for flexibility — it works identically for 0.1mg compound semaglutide or 2.4mg brand-name Wegovy.
Enter your exact dose in mg or units — 0.15mg, 0.4mg, 1.2mg, whatever your prescription specifies. No dropdown limited to standard doses. Log the date, time, and injection site if desired.
Rate nausea, fatigue, GI discomfort, injection site reactions, and other symptoms on a 1–10 scale. Over time, tr8ck shows whether side effects are improving at the current dose or escalating in a way that warrants a dose adjustment conversation.
When you increase your compound dose, tr8ck marks the escalation date and then shows how weight, energy, side effects, and appetite changed in the weeks following — your personal dose-response data.
The same AI correlation engine used by brand-name GLP-1 users works identically for compound users — surfacing patterns between dose timing, nutrition, sleep, mood, energy, and weight that inform smarter health decisions.
What 8 weeks of tracked data reveals
Week 1–2 at 0.25mg
Nausea: 6/10 first 3 days, then 2/10. Weight loss: 1.8 lbs. Energy: 4/10 initially, rising to 6/10 by end of week 2.
Week 3–4 at 0.25mg
Side effects stabilized. Weight loss: 2.1 lbs. Energy averaging 7/10. Sleep quality improved. Protein tracking showed need to increase from 65g to 90g.
Week 5–8 at 0.5mg
Dose escalation spike: nausea 5/10 for days 1–4, then resolved. Weight loss accelerated to 2.8 lbs/week. AI flagged loss rate as elevated — prompts prescriber discussion.
Both need comprehensive tracking. Here's how the needs differ.
| Tracking Need | Brand-Name (Ozempic/Wegovy) | Compound Semaglutide |
|---|---|---|
| Dose entry flexibility | Fixed doses (0.25, 0.5, 1.0, 2.4mg) | Any custom dose amount — essential for compound users |
| Dose escalation tracking | Follows standard manufacturer schedule | Custom escalation schedule — tracking is how you know when to escalate |
| Side effect monitoring | Important — side effects are documented | Critical — formulation variability means side effects need careful individual monitoring |
| Weight loss rate tracking | Helpful for optimization | Essential — no population data to compare against; personal data is the benchmark |
| Prescriber data sharing | Useful for appointments | Often critical — telehealth prescribers need objective data for remote dose management |
Yes — tr8ck's medication module accepts any custom dose amount and frequency. You enter your exact mg dose (e.g., 0.15mg, 0.4mg, 1.2mg), the date, and any side effects. There are no locked-in brand-name dose options. tr8ck works identically for compound semaglutide as it does for Ozempic or Wegovy.
Tracking is more critical for compound users because there's no standardized dose schedule — escalation is based on individual response. Side effects can vary more. And without population-level benchmarks for your specific formulation, your personal tracked data IS your reference point for evaluating effectiveness and tolerability.
tr8ck is specifically well-suited for compound users because of its flexible dose entry, comprehensive health modules, and AI correlation engine. Most GLP-1 apps are built around fixed Ozempic/Wegovy schedules and don't accommodate custom doses well. tr8ck's approach — log any dose, see how all health metrics respond — is exactly what compound users need.
Compounded semaglutide contains the same active molecule. When sourced from an accredited compounding pharmacy using pharmaceutical-grade ingredients, it can be equally effective. Tracking your personal weight loss rate, side effect profile, and health outcomes with tr8ck is the best way to evaluate how your specific compound formulation is working for you.
Dose finding is a process of tracked escalation. Start with the lowest prescribed dose, log side effects and weight response for 2–4 weeks in tr8ck, then review with your prescriber. tr8ck's AI identifies your side effect-to-weight loss ratio at each dose level — helping you and your prescriber find the optimal balance of efficacy and tolerability.
tr8ck is the only health tracking app flexible enough for compound semaglutide users — log any dose, any frequency, and see exactly how it's affecting your weight, energy, sleep, and overall health.
Start tracking freeAlso worth reading